The dried, powdered root of the turmeric plant has a long history of use as an Ayurvedic treatment of various inflammatory conditions. Curcumin is well known for its potent antioxidant properties, and has been linked to promotion of anti-inflammatory conditions in tissues that can play a vital role in joint health, brain health, gut and cardiovascular health.
While the biological effects of curcumin and its mechanism of action have been well-studied, its limited bioavailability is a major issue with respect to its use in an oral dose form. Because of low absorption and rapid metabolism, very high intake levels of a standard extract are needed to be biologically effective. A unique technology that makes these compounds highly soluble solves this problem and drastically increases bioavailability.
The NovaSOL® solubilisation technology gives curcumin unique properties which result in rapid absorption and high bioavailability.
A published human clinical trial shows the superior bioavailability of NovaSOL® Curcumin over standard curcumin extracts.
This very stable, highly bioavailable solubilisate means that the ingredient can be used at much lower doses in orally ingested product.